| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.2 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.28 | 0.05 |